featured
Immune-Mediated Colitis Associated With Ocrelizumab Treatment
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
Multiple Sclerosis (Houndmills, Basingstoke, England)
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Immune-mediated colitis associated with ocrelizumab: A new safety risk
Mult. Scler. 2023 Sep 01;29(10)1275-1281, T Kim, A Brinker, D Croteau, PR Lee, LE Baldassari, J Stevens, A Hughes, J Tomaino, A deFonseka, T Altepeter, CM KortepeterFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.